Reference
Polverino, Francesca, et al. “Comorbidities, Cardiovascular Therapies, and {COVID-19} Mortality: A Nationwide, Italian Observational Study ({ItaliCO})”. Front. Cardiovasc. Med., vol. 7, Oct. 2020, p. 585866.
Abstract
Background: Italy has one of the world's oldest populations, and
suffered one the highest death tolls from Coronavirus disease
2019 (COVID-19) worldwide. Older people with cardiovascular
diseases (CVDs), and in particular hypertension, are at higher
risk of hospitalization and death for COVID-19. Whether
hypertension medications may increase the risk for death in
older COVID 19 inpatients at the highest risk for the disease is
currently unknown. Methods: Data from 5,625 COVID-19 inpatients
were manually extracted from medical charts from 61 hospitals
across Italy. From the initial 5,625 patients, 3,179 were
included in the study as they were either discharged or deceased
at the time of the data analysis. Primary outcome was inpatient
death or recovery. Mixed effects logistic regression models were
adjusted for sex, age, and number of comorbidities, with a
random effect for site. Results: A large proportion of
participating inpatients were $\geq$65 years old (58%), male
(68%), non-smokers (93%) with comorbidities (66%). Each
additional comorbidity increased the risk of death by 35%
[adjOR = 1.35 (1.2, 1.5) p < 0.001]. Use of ACE inhibitors,
ARBs, beta-blockers or Ca-antagonists was not associated with
significantly increased risk of death. There was a marginal
negative association between ARB use and death, and a marginal
positive association between diuretic use and death.
Conclusions: This Italian nationwide observational study of
COVID-19 inpatients, the majority of which $\geq$65 years old,
indicates that there is a linear direct relationship between the
number of comorbidities and the risk of death. Among CVDs,
hypertension and pre-existing cardiomyopathy were significantly
associated with risk of death. The use of hypertension
medications reported to be safe in younger cohorts, do not
contribute significantly to increased COVID-19 related deaths in
an older population that suffered one of the highest death tolls
worldwide.